Court Halts Oncoclínicas Shareholder Meeting
A São Paulo court suspended the 6 November shareholder meeting at Oncoclínicas, a major Brazilian private cancer-care chain, and no new date is set. The post Court Halts Oncoclínicas Shareholder Meeting appeared first on The Rio Times .
A Brazilian court has halted a planned shareholder meeting for Oncoclínicas do Brasil, a private cancer treatment company, due to a dispute over a mandatory offer. The meeting, originally scheduled for November 6, 2026, has been indefinitely postponed. The chain is currently restructuring its debts and is embroiled in a contentious board dispute.
Josephina III, a fund linked to Centaurus Capital, is seeking to convene the meeting. The company's shares are listed on B3, the São Paulo stock exchange, under the ticker symbol ONCO3. The company's board was elected via cumulative voting, meaning one resignation triggers a board-wide re-election. As a result, Oncoclínicas' board member Paulo Roberto Belem Junior tendered his resignation on September 30, 2026, triggering the need for a new meeting.
The company has not yet announced a new date for the meeting, as the outcome of the arbitration dispute over the mandatory offer remains unresolved.
Written by urgent.news from The Rio Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
